- Home
- ELVN vs CAL Comparison
ELVN vs CAL Comparison
Compare ELVN & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- CAL
- Stock Information
- Founded
- ELVN 2016
- CAL 1878
- Country
- ELVN United States
- CAL United States
- Employees
- ELVN N/A
- CAL N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- ELVN Health Care
- CAL Consumer Discretionary
- Exchange
- ELVN Nasdaq
- CAL Nasdaq
- Market Cap
- ELVN 1.1B
- CAL 1.1B
- IPO Year
- ELVN 2020
- CAL N/A
- Fundamental
- Price
- ELVN $21.48
- CAL $20.65
- Analyst Decision
- ELVN Strong Buy
- CAL Hold
- Analyst Count
- ELVN 5
- CAL 2
- Target Price
- ELVN $37.80
- CAL $30.00
- AVG Volume (30 Days)
- ELVN 212.9K
- CAL 833.7K
- Earning Date
- ELVN 11-13-2024
- CAL 12-05-2024
- Dividend Yield
- ELVN N/A
- CAL 1.32%
- EPS Growth
- ELVN N/A
- CAL 3.15
- EPS
- ELVN N/A
- CAL 4.49
- Revenue
- ELVN N/A
- CAL $2,780,579,000.00
- Revenue This Year
- ELVN N/A
- CAL N/A
- Revenue Next Year
- ELVN N/A
- CAL $1.07
- P/E Ratio
- ELVN N/A
- CAL $4.71
- Revenue Growth
- ELVN N/A
- CAL N/A
- 52 Week Low
- ELVN $10.90
- CAL $20.97
- 52 Week High
- ELVN $30.03
- CAL $44.51
- Technical
- Relative Strength Index (RSI)
- ELVN 38.87
- CAL 29.71
- Support Level
- ELVN $21.55
- CAL $21.75
- Resistance Level
- ELVN $25.37
- CAL $22.61
- Average True Range (ATR)
- ELVN 1.53
- CAL 0.97
- MACD
- ELVN 0.10
- CAL 0.06
- Stochastic Oscillator
- ELVN 8.33
- CAL 14.38
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.
About CAL Caleres Inc.
Caleres Inc is a footwear retailer in the United States. The Company's business are organized into two reportable segments are famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of famous Footwear retail stores, famousfootwear.com and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a carefully cultivated portfolio of top brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear to online retailers, national chains, department stores, mass merchandisers and independent retailers, as well as Company owned famous Footwear, Sam Edelman, Naturalizer and Allen Edmonds stores and e-commerce businesses.